3 results  1 of 1 

1 A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets
Rachna Arora, Manju Sharma, Tausif Monif, Sunil Iyer
Cancer Res Treat.2016;48(3):1120-1129.   Published online 2016 February 12     DOI: http://dx.doi.org/10.4143/crt.2015.436
      
2 Pharmacodynamic Comparison of Two Formulations of Voglibose 0.3-mg Tablet
Mi Jo Kim, Hyeong-Seok Lim, Sang-Heon Cho, Kyun-Seop Bae
J Korean Soc Clin Pharmacol Ther.2013;21(1):34-40.   Published online 2013 January 11     DOI: http://dx.doi.org/10.12793/jkscpt.2013.21.1.34
   
3 Simulation of the AUC Changes after Generic Substitution in Patients
Dong-Seok Yim
J Korean Med Sci.2009;24(1):7-12.   Published online 2009 February 28     DOI: http://dx.doi.org/10.3346/jkms.2009.24.1.7
      

 1 of 1